[Lab] 14th independent test on QSC, and the trend is the interesting part
Right, the triple agonist question again, but with numbers this time.
I have 19 data points over 4 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.
The thing I would flag for anyone new: the effect I am describing showed up at week 58, not week 12. People give up long before the interesting part.
Interested in whether this matches other people's logs or whether I am an outlier.
best — the order this archive was captured in
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
research use only, handling and analysis, not protocols
Strongly agree. Heart rate escalation needs the actual data, not impressions.
the glucagon component changes the side effect profile, not just the efficacy
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
Small correction: the trial was 4 weeks, not 32. Does not change your point but people will quote it.
Which trial arm and what was the n?
the glucagon component changes the side effect profile, not just the efficacy
the glucagon component changes the side effect profile, not just the efficacy
the dosing is steep, the sulphur burps reports are real, and nobody knows the human safety yet
the weight curves are unusually steep, which makes predicting individual response harder
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
Respectfully this is a sample of one presented as a finding.
Small correction: the trial was 2 weeks, not 10. Does not change your point but people will quote it.
Small correction: the trial was 2 weeks, not 10.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
the glucagon component changes the side effect profile, not just the efficacy
triple agonism is glucagon, do not generalise
Slight fix: the number was 97.6, not 97.4. Decimal point, but a fairly consequential one.
Slight fix: the number was 97.6, not 97.4.
Yes, exactly this, and it is the bit that took me 8 weeks to accept.
the dosing is steep, the muscle cramps reports are real, and nobody knows the human safety yet
nobody should be giving this to anyone without extensive monitoring
the weight curves are unusually steep, which makes predicting individual response harder
nobody should be giving this to anyone without extensive monitoring
- 1Dose escalation on retatrutide is steeper and faster than on semaglutide. Do…12 comments in this branch · started by u/reflux_report
- 2Which trial arm and what was the n?6 comments in this branch · started by u/sofia_wikstrom